Loading…
Mercola.com, LLC was cited for marketing three nutritional supplement products (Liposomal Vitamin C, Liposomal Vitamin D3, and Quercetin and Pterostilbene Advanced) with claims that they could mitigate, prevent, treat, diagnose, or cure COVID-19, thereby violating the Federal Food, Drug, and Cosmetic Act. The products were determined to be unapproved new drugs under section 505(a) and misbranded drugs under section 502 of the FD&C Act, with their introduction into interstate commerce prohibited. The FDA took urgent enforcement action during the declared public health emergency and national emergency related to COVID-19 to protect consumers from unauthorized disease-treatment claims.